Toxicogenomics: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 25: | Line 25: | ||
{{genomics-stub}} | {{genomics-stub}} | ||
{{toxicology-stub}} | {{toxicology-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 13:19, 18 March 2025
Toxicogenomics is a scientific discipline that combines the study of toxicology with genomics to understand the response of an organism's genome to harmful substances. It is a rapidly evolving field that has the potential to revolutionize our understanding of toxicology and human health.
Overview[edit]
Toxicogenomics involves the application of genomic technologies, such as DNA sequencing, gene expression profiling, and bioinformatics, to study the effects of toxins on the genome. The goal is to understand how the genome responds to toxins at the molecular level, and how these responses can lead to adverse health effects.
History[edit]
The field of toxicogenomics emerged in the late 1990s, following the completion of the Human Genome Project. The project's success in mapping the human genome opened up new possibilities for studying the effects of toxins on the genome.
Applications[edit]
Toxicogenomics has a wide range of applications in both research and clinical settings. It can be used to identify genetic markers of susceptibility to toxins, to understand the mechanisms of toxicity, and to develop new methods for assessing the safety of chemicals and drugs.
Challenges[edit]
Despite its potential, toxicogenomics also faces several challenges. These include the complexity of the genome, the difficulty of interpreting genomic data, and the need for standardized methods and protocols.
Future Directions[edit]
The future of toxicogenomics is likely to be shaped by advances in genomic technologies and by the increasing recognition of the importance of understanding the genomic basis of toxicity.

This article is a toxicology-related stub. You can help WikiMD by expanding it!
